Pseudotumor cerebri medical therapy

Jump to navigation Jump to search

Pseudotumor cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating pseudotumor cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudotumor cerebri medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudotumor cerebri medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudotumor cerebri medical therapy

CDC on Pseudotumor cerebri medical therapy

Pseudotumor cerebri medical therapy in the news

Blogs on Pseudotumor cerebri medical therapy

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pseudotumor cerebri medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Medical Therapy

Medical treatment

Pharmacologic medical therapies for pseudotumor cerebri include:

1.Carbonic anhydrase inhibitors

Carbonic anhydrase inhibitors like acetazolamide reduce cerebrospinal fluid production and reduce the CSF pressure, papilledema and visual field loss.(3_16 uptodate darman). The starting dose is 500 mg twice a day for adults which we can increase to 2-4 gr a day. In young children we start with 25mg/kg and increase it to 100 mg/kg or 2 gr a day.(36) Another drug in this group is topiramate which is an antizeizure drug but can inhibit carbonic anhydrase activity too. Case reports suggest that topiramate can reduce symptoms and visual field loss in IIH patients.(45 ta 49)

2.Loop diuretics

In addition to acetazolamide we can use loop diuretics like furosemide with the start dose of 20 to 40 mg per day for adults and 1 to 2 mg/kg per day in children. Studies suggest that treatment with both acetazolamide and furosemide can rapidly reduce CSF pressure and papilledema(36-50)

3.Corticosteroids

In the past, prednisone was suggested for IIH patients but nowadays we avoid using them for long term treatment because of following reasons:

  • Weight gain and worsening of symptoms
  • Steroid withdrawal which is one of the IIH risk factors
  • Systemic side effects(51)

4.Indomethacin

This drug is believed to reduce the CSF pressure by cerebral vasoconstriction and reducing blood flow(53)

5.Iron

Treatment of iron deficiency anemia can improve IIH patients symptoms(55)

6.analgesics

We can use analgesics to control headaches. Overusing of analgesics can cause rebound headaches which should be avoided.(56)

Non medical treatment

Weight loss with low soduim diet is helpful in IIH patients and can reduce CSF pressure, papilledema and disease symptoms.(3-25-28)

References

Template:WH Template:WS